Alexion Pharmaceuticals, Inc. (ALXN)

[Inthe203]

CASH IN WHILE IT'S ON A HIGH!

https://seekingalpha.com/news/3273272-alexion-sputtering-kanuma-launch-write-looming

In this seeking alpha article, it clearly indicates where this company is heading. CEO Ludwig Hantson, is notorious for going into Pharmas, trimming the fat and preparing it for a buyout. That executive team that he brought in? They're all a part of the buyout team he formed in the other companies he spearheaded.

As you can see here, he's trimming the fat and I suspect he's getting rid of Alexion's metabolical area which has proven to be disastrous to the company. The article mentions Kanuma being written off, but I suspect that Strensiq will be a part of the deal as well, as both drugs has performed poorly in sales. The didn't include Strensiq as not to alarm the shareholders, but clearly that drug's sales performance is poor as well.

This means Alexion will become a one-hit-wonder again which will result in another wave of massive layoffs which I can only imagine will come before August in my opinion.

I don't even think there's anything else in the company's pipeline that's worthy at this point, is there?

The question is, who's buying them out?